GTHCX Mutual Fund

NAV$18.79

TER1.82%

Holdings81

See how much of GTHCX you already own

Just $25 once·$99/mo·Download sample

X-ray my portfolio free

GTHCX Mutual Fund

NAV$18.79

Invesco Health Care Fund Class C

TER1.82%

Holdings81

See how much of GTHCX you already own

Just $25 once·$99/mo·Download sample

X-ray my portfolio free

Overview Performance Chart Dividends Top Holdings All Holdings Sectors Geography Similar Compare Overlap

Showing top 50 of 81 holdings · as of Mar 31, 2026

GTHCX holdings, by weight
#	Ticker	Name	Weight	Cumulative	Sector	Industry
1	LLY	Eli Lilly & Co.Health Care · Pharmaceuticals	9.07%	9.1%	Health Care	Pharmaceuticals
2	JNJ	Johnson & Johnson -Health Care · Pharmaceuticals	5.81%	14.9%	Health Care	Pharmaceuticals
Sector and industry · Pro
3	—	AstraZeneca PLC	4.34%	19.2%
4	GILD	Gilead Sciences	4.10%	23.3%
5	ABBV	AbbVie Inc.	3.67%	27.0%
6	COR	Cencora Inc	3.65%	30.6%
7	MCK	Mckesson Corp	3.59%	34.2%
8	—	Argenx Se Sponsored Adr (1 Ads : 1 Ordinary)	3.37%	37.6%
9	Debt	Invesco Treasury Portfolio	2.75%	40.4%
10	MRK	Merck & Company Inc	2.27%	42.6%
11	WELL	Welltower, Inc.	2.08%	44.7%
12	HCA	Hca Healthcare, Inc.	2.04%	46.7%
13	—	Nvaesrtex Pharmaceuticals Inc	1.98%	48.7%
14	—	Royalty Pharma PLC - Class A Shares	1.84%	50.6%
15	BTSG	Brightspring Health Services	1.79%	52.4%
16	INSM	Insmed Inc	1.72%	54.1%
17	CAH	Cardinal Health Inc.	1.68%	55.8%
18	REGN	Regeneron Pharmaceuticals, Inc.	1.67%	57.4%
19	TMO	Thermo Fisherscientific Inc.	1.56%	59.0%
20	GH	Guardant Health Inc	1.53%	60.5%
21	—	Ucb Sa	1.53%	62.0%
22	NTRA	Natera Inc	1.50%	63.5%
23	CVGXX	Invesco Government & Agency Portfolio	1.45%	65.0%
24	IDXX	Idexx Labs	1.43%	66.4%
25	BBIO	Bridgebio Pharma Inc	1.40%	67.8%
26	UNH	Unitedhealth Group Inc	1.40%	69.2%
27	AXSM	Axsome Therapeutics, Inc.	1.29%	70.5%
28	—	Intuitive Surg	1.23%	71.7%
29	UTHR	United Therapeutics Corp	1.19%	72.9%
30	SDZ	Sandoz Group Ag	1.16%	74.1%
31	MTD	Mettler-Toledo International Inc.	1.15%	75.2%
32	EW	Edwards Lifesciences Corp	1.11%	76.4%
33	BSX	Boston Scientific Corp.	1.10%	77.5%
34	—	Ascendis Pharma As Adr	1.08%	78.5%
35	THC	Tenet Healthcare Corp	1.08%	79.6%
36	MDGL	Madrigal Pharmaceuticals Inc	0.97%	80.6%
37	PTGX	Protagonist Therapeutics Inc	0.96%	81.5%
38	CVS	Cvs Health Corp.	0.94%	82.5%
39	—	Emcompass Health Corp	0.91%	83.4%
40	MDLN	Medline Inc	0.88%	84.3%
41	HALO	Halozyme Therapeutics Inc	0.87%	85.1%
42	GALD	Galderma Group Ag Registered Shares	0.85%	86.0%
43	LONN	Lonza Group Ag	0.83%	86.8%
44	LGND	Ligand Pharmaceuticals, Inc.	0.79%	87.6%
45	IONS	Ionis Pharmaceuticals Inc	0.70%	88.3%
46	GMED	Globus Medical, Inc. (Class A)	0.66%	89.0%
47	LH	Labcorp Holdings Inc	0.65%	89.6%
48	—	Steris Plc Ordinary Shares	0.64%	90.3%
49	DGX	Quest Diagnostics Inc	0.61%	90.9%
50	MEDP	Medpace Holdings Inc	0.52%	91.4%
More holdings · Pro

Not reported for this fund: shares, market value, share changes.

FundXLS Pro

See the other 31 holdings of GTHCX

X-ray every fund you own at once, ETFs and mutual funds that hold stocks directly, and see how much of your money lands on the same stocks twice.

Unlock FundXLS Pro$45/quarter Pro · Cancel anytime

GTHCX Mutual Fund All Holdings

GTHCX holdings total 81 positions. The top 10 holdings account for 42.6% of the fund, led by Eli Lilly & Co. at 9.1%, Johnson & Johnson - Common at 5.8%, AstraZeneca PLC at 4.3%.

GTHCX portfolio concentration is moderate, with the top 10 representing 42.6% of total assets. The largest sector exposure is Health Care at 82.6%.

GTHCX sectors provide a detailed breakdown. GTHCX overlap shows how holdings compare to other funds in your portfolio.